PM chairs key Covid meet as festival season starts

New Delhi: Amid concerns about resurgence of Covid-19 cases in some cities in the wake of the festival seasonPrime Minister Narendra Modi on Friday stressed on the need for constant genome sequencing to monitor emergence of mutants.

PM Modi was chairing a high-level meeting to take stock of the Covid-19 situation in the country as well as the vaccination status.

INSACOG now consists of 28 labs across the country with the lab network linked with a hospital network for clinical correlation. Besides, sewage sampling is also being done for genomic surveillance, officials apprised the PM during the meeting. The PM also underlined the need to augment healthcare infrastructure and asked states to maintain buffer stock of medicines in every district. He also reviewed production, supply and pipeline of vaccines for the next few months.

During the meeting, PM Modi discussed that across the world, there are countries where the number of active Covid cases continues to remain high. In India too, the figures from states like Maharashtra and Kerala, indicate that there can be no room for complacency, officials pointed out.

The principal secretary to PM, cabinet secretary, principal scientific adviser, health secretary and member health NITI Aayog were among the officials were present in the meeting. Around 39 districts have weekly positivity above 10%. However, the overall weekly positivity has stabilised at below 3% for the tenth consecutive week.

  • Related Posts

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis